Combination of reactive oxygen species and tissue-type plasminogen activator enhances the induction of gelatinase B in brain endothelial cells

International Journal of Neuroscience

Volumn 122, Issue 2, 2012, Pages 53-59

  Harada, Kosuke ^a   Suzuki, Yasuhiro ^a   Yamakawa, Kasumi ^a   Kawakami, Junichi ^a   Umemura, Kazuo ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

edaravone; endothelial cells; matrix metalloprotease 9; reactive oxygen species; tissue type plasminogen activator

Indexed keywords

GELATINASE B; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NORPHENAZONE; REACTIVE OXYGEN METABOLITE; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL CULTURE; ENDOTHELIUM CELL; ENZYME INDUCTION; ENZYME SYNTHESIS; MOUSE; NONHUMAN; NUCLEUS ACCUMBENS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIPYRINE; BRAIN; CELL LINE, TRANSFORMED; CELLS, CULTURED; DRUG INTERACTIONS; ENDOTHELIAL CELLS; ENZYME INDUCTION; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; I-KAPPA B PROTEINS; MATRIX METALLOPROTEINASE 9; MICE; NF-KAPPA B; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84855763426     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2011.623808     Document Type: Article

References (16)

1. Adibhatla RM, Hatcher JF. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol Discord Drug Target. 2008;7:243-53
2. Behard K, Krause KH. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev. 2007;87:245-313
3. Cheng T, Petraglia AL, Li Z, Thiyagarajan M, Zhong Z, Wu Z, Liu D, Maggirwar SB, Deane R, Fernandez JA, LaRue B, Griffin JH, Chopp M, Zlokovic BV. Activated protein C inhibits tissue plasminogen activator-induced brain hemorrhage. Nat Med. 2006;12:1278-85 (Pubitemid 44706930)
4. del Zoppo GJ. Antithrombotic treatments in acute ischemic stroke. Thromb Haemost. 1999;2:938-46
5. Godfrey KR, Tanswell P, Bates RA, Chappel MJ, Madden FN. Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species: a comparison of mathematical models. Biopharm Drug Dispos. 1998;19:131-40 (Pubitemid 28114327)
6. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, Hennerici M. ECASS Study Group, Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA. 1995;274:1017-25
7. Hiu T, Nakagawa S, Hayashi K, Kitagawa N, Tsutsumi K, Kawakubo J, Honda M, Suyama K, Nagata I, Niwa M. Tissue plasminogen activator enhances the hypoxia/reoxygenationinduced impairment of the blood-brain barrier in a primary culture of rat brain endothelial cells. Cell Mol Neurobiol. 2008;28:1139-46
8. Kolev K, Skopal J, Simon L, Csonka E, Machovich R, Nagy Z. Matrix metalloproteinase-9 expression in post-hypoxic human brain capillary endothelial cells:H2O2 as a trigger and NFkappaB as a signal transducer. Thromb Haemost. 2003;90:528-37 (Pubitemid 37138779)
9. Zhao B, Suzuki Y, Kondo K, Ikeda Y, Umemura K. Combination of a free radical scavenger and heparin reduces cerebral hemorrhage after heparin treatment in a rabbit middle cerebral artery occlusion model. Stroke. 2001;32:2157-63. (Pubitemid 32868116)
10. Ridder DA, Schwaninger M. NF-?B signaling in cerebral ischemia. Neuroscience. 2009;158:995-1006
11. Stermlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol. 2001;17:463-516 (Pubitemid 33096184)
12. Wang X, Lee S, Arai K, Lee S, Tsuji K, Rebeck GW, Lo EH. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med. 2003;9:1313-7 (Pubitemid 37279856)
13. Watanabe T, Tahara M, Todo S. The novel antioxidant edaravone: from bench to bedside. Cardiovasc Ther. 2008;26:101-14 (Pubitemid 351952827)
14. Yagi K, Kitazato K, Uno M, Tada Y, Kinouchi T, Shimada K, Nagahiro S. Edaravone, a free radical scavenger, inhibits MMP- 9-related brain hemorrhage in rats treated with tissue plasminogen activator. Stroke. 2009;40:626-631
15. Lapchak PA. Tumor necrosis factor-a is involved in thrombolytic-induced hemorrhage following embolic strokes in rabbits. Brain Res. 2007;1167:123-8 (Pubitemid 47302440)
16. Zhang C, An J, Strickland D, Yepes M. The low-density lipoprotein receptor-related protein-1 mediates tissue-type plasminogen activator-induced microglial activation in the ischemic brain. Am J Pathol. 2009;174:586-94